Evan Wolf, PhD
Ophthalmology · Wasilla, AKNPI 1205801586
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 69 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $713 and has fallen 84.2% since, to $113 in 2025.
Across 69 payments — averaging $35.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$533
- AbbVie$431
- Mallinckrodt Hospital Products Inc.$324
- Novartis$224
- Mallinckrodt Enterprises LLC$180
- Bausch & Lomb Americas Inc.$130
- plus $594 from 10 others
What the payments were for
- Food & beverage$2,417100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 8 | $533 |
| AbbVie(2 entities) | 10 | $431 |
| Mallinckrodt Hospital Products Inc. | 11 | $324 |
| Novartis | 11 | $224 |
| Mallinckrodt Enterprises LLC | 8 | $180 |
| Bausch & Lomb Americas Inc. | 6 | $130 |
| Glaukos Corporation | 1 | $121 |
| Ellexiscience | 1 | $119 |
| Biotissue Holdings Inc. | 4 | $79 |
| Carl Zeiss Meditec, Inc. | 1 | $76 |
| Oyster Point Pharma, Inc. | 2 | $54 |
| Sun Pharmaceutical Industries Inc. | 2 | $44 |
| Astellas Pharma US Inc | 1 | $30 |
| Zimmer Biomet | 1 | $29 |
| Dompe US, Inc. | 1 | $23 |
| Coopervision Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,417 in reported general payments places this provider in the 75th percentile of 30 ophthalmology providers in Alaska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 202 | $10,886 |
| Ketorolac Tromethamine | 195 | $5,340 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 162 | $1,285 |
| MoxifloxacinMoxifloxacin Hcl | 29 | $908 |
| Latanoprost | 37 | $795 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 30 | $514 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Wasilla
- Eric CoulterAnchorage$7K
- Katherine JohnsonFairbanks$6K
- Charlton StevensJber$6K
- Carl RosenAnchorage$4K
- Elizabeth MorganAnchorage$3K
- Don DavisAnchorage$3K
- Eileen MyersAnchorage$2K
- Scott LimstromAnchorage$2K
- Andrew PlasterJber$2K
- Kelly LorenzAnchorage$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.